RCAI-61, the 6′-O-methylated analog of KRN7000: its synthesis and potent bioactivity for mouse lymphocytes to produce interferon-γ in vivo

Tetrahedron Letters

Volumn 49, Issue 48, 2008, Pages 6827-6830

  Tashiro, Takuya ^a   Nakagawa, Ryusuke ^b   Inoue, Sayo ^b   Shiozaki, Masao ^a   Watarai, Hiroshi ^b   Taniguchi, Masaru ^a,b   Mori, Kenji ^a  

^a Research Center for Allergy and Immunology   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Galactosylceramides; CD1d; IFN ; KRN7000

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; ANTINEOPLASTIC AGENT; CARBOHYDRATE DERIVATIVE; GALACTOSE; GAMMA INTERFERON; METHYL ALPHA DEXTRO GALACTOPYRANOSIDE; METHYL BETA LEVO ARABINOPYRANOSIDE; RCAI 56; RCAI 58; RCAI 61; RCAI 64; RCAI 83; RCAI 85; RCAI 86; RCAI 87; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG SYNTHESIS; LYMPHOCYTE; MOUSE; NONHUMAN;

EID: 53549099648     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2008.09.074     Document Type: Article

References (28)

1. Morita M., Motoki K., Akimoto K., Natori T., Sakai T., Sawa E., Yamaji K., Koezuka Y., Kobayashi E., and Fukushima H. J. Med. Chem. 38 (1995) 2176-2187
2. Natori T., Koezuka Y., and Higa T. Tetrahedron Lett. 34 (1993) 5591-5592
3. Natori T., Morita M., Akimoto K., and Koezuka Y. Tetrahedron 50 (1994) 2771-2776
4. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., and Taniguchi M. Science 278 (1997) 1626-1629
5. Wu D., Xing G.-W., Poles M.A., Horowitz A., Kinjo Y., Sullivan B., Bodmer-Narkevitch V., Plettenburg O., Kronenberg M., Tsuji M., Ho D.D., and Wong C.-H. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 1351-1356
6. Rissoan M.-C., Soumelis V., Kadowaki N., Grouard G., Briere F., Malefyt R.d.W., and Liu Y.-J. Science 283 (1999) 1183-1186
7. See recently published review:. Wu D., Fujio M., and Wong C.-H. Bioorg. Med. Chem. 16 (2008) 1073-1083
8. Zajonc D.M., Cantu III C., Mattner J., Zhou D., Savage P.B., Bendelac A., Wilson I.A., and Teyton L. Nat. Immunol. 6 (2005) 810-818
9. Koch M., Stronge V.S., Shepherd D., Gadola S.D., Mathew B., Ritter G., Fersht A.R., Besra G.S., Schmidt R.R., Jones E.Y., and Cerundolo V. Nat. Immunol. 6 (2005) 819-826
10. Borg N.A., Wun K.S., Kjer-Nielsen L., Wilce M.C.J., Pellicci D.G., Koh R., Besra G.S., Bharadwaj M., Godfrey D.I., McCluskey J., and Rossjohn J. Nature 448 (2007) 44-49
11. Xing G.-W., Wu D., Poles M.A., Horowitz A., Tsuji M., Ho D.D., and Wong C.-H. Bioorg. Med. Chem. 13 (2005) 2907-2916
12. Kinjo Y., Wu D., Kim G., Xing G.-W., Poles M.A., Ho D.D., Tsuji M., Kawahara K., Wong C.-H., and Kronenberg M. Nature 434 (2005) 520-525
13. Mattner J., DeBord K.L., Ismail N., Goff R.D., Cantu III C., Zhou D., Saint-Mezard P., Wang V., Gao Y., Yin N., Hoebe K., Schneewind O., Walker D., Beutler B., Teyton L., Savage P.B., and Bendelac A. Nature 434 (2005) 525-529
14. Zhou X.-T., Forestier C., Goff R.D., Li C., Teyton L., Bendelac A., and Savage P.B. Org. Lett. 4 (2002) 1267-1270
15. Liu Y., Goff R.D., Zhou D., Mattner J., Sullivan B.A., Khurana A., Cantu III C., Ravkov E.V., Ibegbu C.C., Altman J.D., Teyton L., Bendelac A., and Savage P.B. J. Immunol. Methods 312 (2006) 34-39
16. Bernotas R.C., Pezzone M.A., and Ganem B. Carbohydr. Res. 167 (1987) 305-311
17. Koto S., Kusunoki A., and Hirooka M. Bull. Chem. Soc. Jpn. 73 (2000) 967-976
18. Tatsuta K., Niwata Y., Umezawa K., Toshima K., and Nakata M. Carbohydr. Res. 222 (1991) 189-203
19. Kovác P., Yeh H.J.C., and Jung G.L. J. Carbohydr. Chem. 6 (1987) 423-439
20. Koto S., Morishima N., Takenaka K., Kanemitsu K., Shimoura N., Kase M., Kojiro S., Nakamura T., Kawase T., and Zen S. Bull. Chem. Soc. Jpn. 62 (1989) 3549-3566
21. Motoki K., Morita M., Kobayashi E., Uchida T., Akimoto K., Fukushima H., and Koezuka Y. Biol. Pharm. Bull. 18 (1995) 1487-1491
22. Takikawa H., Muto S., and Mori K. Tetrahedron 54 (1998) 3141-3150
23. Mukaiyama T., Murai Y., and Shoda S. Chem. Lett. (1981) 431-432
24. + 872.7555; found, 872.7553.
25. We reported the standard protocol for detection, isolation, and culture of mouse and human invariant NKT cells. See:. Watarai H., Nakagawa R., Omori-Miyake M., Dashtsoodol N., and Taniguchi M. Nat. Protocols 3 (2008) 70-78
26. The serum samples were obtained at indicated time points after injection (i.v.) of KRN7000 (1) or synthesized analogs (3a-g). Glycolipids: The stock solution of 1 [200 μg/mL in 0.5% polysorbate-20 (MP Biomedicals) or 3a-g [1 mg/mL in dimethyl sulfoxide (DMSO)] was diluted to 10 μg/mL in Dulbecco's phosphate buffered saline (Sigma, Product No. D8537) just before injection into mice. Mice: 8-12-week-old female C57BL/6J mice (Charles River Laboratories, Inc.) Concentration of IFN-γ was measured by ELISA (Pierce Biotechnology, Inc.).
27. Tashiro T., Nakagawa R., Hirokawa T., Inoue S., Watarai H., Taniguchi M., and Mori K. Tetrahedron Lett. 48 (2007) 3343-3347
28. 21